parthenolide has been researched along with Astrocytoma, Grade IV in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Ding, Y; Ge, W; Guo, H; Hao, X; Hu, K; Li, A; Li, J; Li, Y; Liu, S; Wang, D; Wang, T; Xue, Q; Zhang, Q; Zhang, Y | 1 |
| Chen, Y; Li, P; Wang, S; Yu, Z; Yuan, Y; Zhou, G | 1 |
| Chiu, SC; Liao, MH; Lin, CW; Su, MJ; Tang, TK | 1 |
| Battastini, AM; Braganhol, E; Dalmolin, RJ; de Souza, LH; Gelain, DP; Moreira, JC; Pasquali, MA; Schröder, R; Zanotto-Filho, A | 1 |
| Nakabayashi, H; Shimizu, K | 1 |
| Anderson, KN; Bejcek, BE | 1 |
6 other study(ies) available for parthenolide and Astrocytoma, Grade IV
| Article | Year |
|---|---|
Identification of Parthenolide Dimers as Activators of Pyruvate Kinase M2 in Xenografts of Glioblastoma Multiforme in Vivo.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Glioblastoma; Humans; Prodrugs; Protein Kinase Inhibitors; Pyruvate Kinase; Sesquiterpenes; Signal Transduction; STAT3 Transcription Factor; Xenograft Model Antitumor Assays | 2020 |
Inhibition of NF-κB results in anti-glioma activity and reduces temozolomide-induced chemoresistance by down-regulating MGMT gene expression.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Neoplasms; Cell Line, Tumor; DNA Modification Methylases; DNA Repair Enzymes; Down-Regulation; Drug Resistance, Neoplasm; Drug Synergism; Glioblastoma; Humans; Mice; Mice, SCID; Rats; RNA, Small Interfering; Sesquiterpenes; Signal Transduction; Temozolomide; Transcription Factor RelA; Treatment Outcome; Tumor Suppressor Proteins; Xenograft Model Antitumor Assays | 2018 |
Induction of survivin inhibition, G₂/M cell cycle arrest and autophagic on cell death in human malignant glioblastoma cells.
Topics: Antineoplastic Agents; Apoptosis; Autophagy; Cell Line, Tumor; Dose-Response Relationship, Drug; G2 Phase Cell Cycle Checkpoints; Glioblastoma; Humans; Inhibitor of Apoptosis Proteins; M Phase Cell Cycle Checkpoints; Sesquiterpenes; Survivin; Treatment Outcome | 2015 |
NFκB inhibitors induce cell death in glioblastomas.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Astrocytes; Brain Neoplasms; Cell Cycle; Cell Death; Cell Line, Tumor; Cisplatin; Curcumin; Doxorubicin; Drug Synergism; Glioblastoma; Humans; Leupeptins; Molecular Targeted Therapy; NF-kappa B; Nitriles; Oxides; Rats; Sesquiterpenes; Signal Transduction; Sulfones | 2011 |
Involvement of Akt/NF-κB pathway in antitumor effects of parthenolide on glioblastoma cells in vitro and in vivo.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis Regulatory Proteins; Blotting, Western; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Matrix Metalloproteinase 9; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; NF-kappa B; Phosphorylation; Proto-Oncogene Proteins c-akt; Reverse Transcriptase Polymerase Chain Reaction; Sesquiterpenes; Signal Transduction; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2012 |
Parthenolide induces apoptosis in glioblastomas without affecting NF-kappaB.
Topics: Antineoplastic Agents; Apoptosis; Brain Neoplasms; Caspase 3; Caspase 7; Cell Line, Tumor; Glioblastoma; Humans; NF-kappa B; Sesquiterpenes | 2008 |